Display Settings:

Format

Send to:

Choose Destination
Mol Cell Probes. 2011 Apr-Jun;25(2-3):134-6. doi: 10.1016/j.mcp.2011.01.005. Epub 2011 Jan 31.

No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls.

Author information

  • 1Stanley Division of Developmental Virology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD 21287, United States. ssabunc1@jhmi.edu

Abstract

New ELISA assays were developed to measure immunoreactivity for XMRV. Antibody titers were measured in a cohort of prostate cancer cases and cancer free controls from the central United States. No statistically significant differences were observed in immunoreactivity between cases and controls for either the XMRV-env or the XMRV-gag antigen.

Copyright © 2011 Elsevier Ltd. All rights reserved.

PMID:
21281710
[PubMed - indexed for MEDLINE]
PMCID:
PMC3285460
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk